| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.01 | 1 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.0038 | 1 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.01 | 1 |